Concepts (253)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Borrelia burgdorferi | 5 | 2024 | 182 | 1.980 |
Why?
|
Lyme Disease | 6 | 2024 | 630 | 1.710 |
Why?
|
Phylogeny | 4 | 2024 | 2775 | 1.050 |
Why?
|
Genome, Viral | 6 | 2022 | 658 | 0.980 |
Why?
|
Respiratory Syncytial Virus Vaccines | 1 | 2022 | 35 | 0.820 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2023 | 167 | 0.790 |
Why?
|
SAIDS Vaccines | 1 | 2022 | 144 | 0.770 |
Why?
|
Genetic Fitness | 1 | 2022 | 116 | 0.750 |
Why?
|
Babesia microti | 2 | 2019 | 31 | 0.690 |
Why?
|
Gonorrhea | 1 | 2023 | 342 | 0.660 |
Why?
|
Genome, Bacterial | 1 | 2024 | 770 | 0.660 |
Why?
|
Babesiosis | 2 | 2019 | 92 | 0.650 |
Why?
|
Genome, Protozoan | 3 | 2016 | 148 | 0.630 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2023 | 364 | 0.600 |
Why?
|
Encephalitis Viruses, Tick-Borne | 3 | 2024 | 43 | 0.600 |
Why?
|
Plasmodium falciparum | 6 | 2013 | 1741 | 0.570 |
Why?
|
Disease Outbreaks | 3 | 2023 | 1759 | 0.560 |
Why?
|
Papillomavirus Vaccines | 1 | 2022 | 486 | 0.540 |
Why?
|
AIDS Vaccines | 1 | 2022 | 896 | 0.530 |
Why?
|
Influenza Vaccines | 1 | 2022 | 770 | 0.490 |
Why?
|
Antigenic Variation | 1 | 2013 | 118 | 0.440 |
Why?
|
Cell Nucleolus | 1 | 2013 | 156 | 0.430 |
Why?
|
Virus Shedding | 2 | 2022 | 111 | 0.390 |
Why?
|
Encephalitis, Tick-Borne | 2 | 2024 | 37 | 0.380 |
Why?
|
Chromosomes | 1 | 2013 | 575 | 0.360 |
Why?
|
Anti-Bacterial Agents | 2 | 2024 | 7400 | 0.320 |
Why?
|
Metagenomics | 3 | 2024 | 457 | 0.310 |
Why?
|
Protozoan Proteins | 1 | 2013 | 838 | 0.290 |
Why?
|
Antibodies, Neutralizing | 3 | 2024 | 1933 | 0.250 |
Why?
|
Ross River virus | 1 | 2024 | 6 | 0.250 |
Why?
|
Alphavirus Infections | 1 | 2024 | 19 | 0.240 |
Why?
|
Bayes Theorem | 2 | 2022 | 2325 | 0.230 |
Why?
|
Borrelia | 1 | 2024 | 66 | 0.230 |
Why?
|
Central Nervous System Infections | 1 | 2024 | 61 | 0.220 |
Why?
|
Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2022 | 52 | 0.210 |
Why?
|
Virus Cultivation | 1 | 2022 | 88 | 0.210 |
Why?
|
Convalescence | 1 | 2022 | 106 | 0.200 |
Why?
|
Adenosine Monophosphate | 1 | 2024 | 283 | 0.200 |
Why?
|
Measles-Mumps-Rubella Vaccine | 1 | 2022 | 72 | 0.200 |
Why?
|
Genetic Variation | 2 | 2020 | 6540 | 0.200 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2024 | 3618 | 0.200 |
Why?
|
Alanine | 1 | 2024 | 607 | 0.200 |
Why?
|
GATA2 Transcription Factor | 2 | 2013 | 158 | 0.200 |
Why?
|
Humans | 51 | 2024 | 760261 | 0.190 |
Why?
|
Ciprofloxacin | 1 | 2023 | 312 | 0.190 |
Why?
|
Erythema Chronicum Migrans | 1 | 2021 | 48 | 0.190 |
Why?
|
Central Nervous System Viral Diseases | 1 | 2021 | 40 | 0.190 |
Why?
|
Anthozoa | 1 | 2021 | 65 | 0.190 |
Why?
|
Sequence Analysis | 1 | 2021 | 240 | 0.190 |
Why?
|
Neisseria gonorrhoeae | 1 | 2023 | 237 | 0.180 |
Why?
|
Cell Cycle | 1 | 2009 | 2937 | 0.180 |
Why?
|
Neutralization Tests | 1 | 2022 | 729 | 0.180 |
Why?
|
Interferon Type I | 1 | 2024 | 559 | 0.180 |
Why?
|
Meningitis | 1 | 2021 | 218 | 0.170 |
Why?
|
Laboratories, Hospital | 1 | 2021 | 193 | 0.170 |
Why?
|
BCG Vaccine | 1 | 2022 | 371 | 0.170 |
Why?
|
Immunocompromised Host | 2 | 2024 | 857 | 0.170 |
Why?
|
Drug Resistance, Viral | 1 | 2024 | 859 | 0.160 |
Why?
|
Serologic Tests | 1 | 2021 | 383 | 0.160 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2024 | 975 | 0.160 |
Why?
|
Plasmids | 1 | 2023 | 2277 | 0.150 |
Why?
|
DNA Barcoding, Taxonomic | 1 | 2019 | 132 | 0.150 |
Why?
|
Metagenome | 1 | 2021 | 450 | 0.150 |
Why?
|
Encephalitis | 1 | 2021 | 436 | 0.150 |
Why?
|
Viruses | 1 | 2021 | 376 | 0.150 |
Why?
|
Virus Replication | 2 | 2024 | 2431 | 0.150 |
Why?
|
DNA Primers | 1 | 2021 | 2819 | 0.140 |
Why?
|
Gene Expression Profiling | 3 | 2012 | 9388 | 0.140 |
Why?
|
Microbial Sensitivity Tests | 1 | 2023 | 1952 | 0.140 |
Why?
|
HIV Infections | 1 | 2023 | 17159 | 0.140 |
Why?
|
Seasons | 1 | 2023 | 1523 | 0.140 |
Why?
|
Antibodies, Viral | 3 | 2023 | 3145 | 0.140 |
Why?
|
Atovaquone | 1 | 2016 | 56 | 0.140 |
Why?
|
Cytochromes b | 1 | 2016 | 34 | 0.140 |
Why?
|
Microvessels | 1 | 2021 | 572 | 0.140 |
Why?
|
Mutation | 7 | 2024 | 29950 | 0.140 |
Why?
|
RNA, Viral | 2 | 2021 | 2837 | 0.130 |
Why?
|
Drug Resistance, Bacterial | 1 | 2023 | 1054 | 0.130 |
Why?
|
Autoantibodies | 1 | 2024 | 2119 | 0.130 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2020 | 612 | 0.130 |
Why?
|
Zoonoses | 1 | 2016 | 179 | 0.120 |
Why?
|
Polymerase Chain Reaction | 3 | 2021 | 6067 | 0.120 |
Why?
|
Azithromycin | 1 | 2016 | 201 | 0.120 |
Why?
|
Ribosomal Proteins | 1 | 2016 | 359 | 0.110 |
Why?
|
Genotype | 3 | 2023 | 12959 | 0.110 |
Why?
|
Mycobacterium avium-intracellulare Infection | 1 | 2013 | 76 | 0.110 |
Why?
|
DNA, Protozoan | 1 | 2013 | 228 | 0.110 |
Why?
|
DNA, Ribosomal | 1 | 2013 | 285 | 0.100 |
Why?
|
Leukopenia | 1 | 2013 | 212 | 0.100 |
Why?
|
Regression Analysis | 1 | 2022 | 6361 | 0.100 |
Why?
|
Viral Load | 1 | 2021 | 3323 | 0.100 |
Why?
|
Antiviral Agents | 1 | 2024 | 3061 | 0.100 |
Why?
|
Amino Acid Substitution | 1 | 2016 | 1737 | 0.100 |
Why?
|
Ethanolamines | 1 | 2012 | 155 | 0.100 |
Why?
|
Alleles | 1 | 2022 | 6900 | 0.100 |
Why?
|
RNA, Antisense | 1 | 2011 | 136 | 0.100 |
Why?
|
Ritonavir | 2 | 2023 | 328 | 0.100 |
Why?
|
Haploinsufficiency | 1 | 2013 | 329 | 0.090 |
Why?
|
Fluorenes | 1 | 2012 | 157 | 0.090 |
Why?
|
Sequence Analysis, DNA | 2 | 2013 | 4717 | 0.090 |
Why?
|
Mycobacterium Infections | 1 | 2011 | 121 | 0.090 |
Why?
|
Influenza, Human | 1 | 2022 | 1532 | 0.090 |
Why?
|
Nucleic Acid Conformation | 1 | 2013 | 899 | 0.090 |
Why?
|
New England | 2 | 2024 | 1045 | 0.090 |
Why?
|
Mycobacterium | 1 | 2011 | 250 | 0.080 |
Why?
|
Liver Transplantation | 1 | 2021 | 2317 | 0.080 |
Why?
|
Referral and Consultation | 1 | 2022 | 3598 | 0.080 |
Why?
|
Brain Injuries | 1 | 2021 | 2044 | 0.080 |
Why?
|
Genomics | 1 | 2024 | 5790 | 0.080 |
Why?
|
Neutrophils | 1 | 2021 | 3770 | 0.080 |
Why?
|
Boston | 1 | 2020 | 9282 | 0.070 |
Why?
|
Blood | 1 | 2010 | 586 | 0.070 |
Why?
|
Enhancer Elements, Genetic | 1 | 2013 | 1356 | 0.070 |
Why?
|
Whole-Body Irradiation | 1 | 2007 | 433 | 0.070 |
Why?
|
Microfluidics | 2 | 2022 | 654 | 0.070 |
Why?
|
Infant, Newborn | 2 | 2023 | 26168 | 0.070 |
Why?
|
United States | 4 | 2023 | 72363 | 0.060 |
Why?
|
Monocytes | 2 | 2013 | 2574 | 0.060 |
Why?
|
Infant | 3 | 2023 | 36030 | 0.060 |
Why?
|
Chromosome Mapping | 1 | 2013 | 4625 | 0.060 |
Why?
|
Antimalarials | 1 | 2012 | 907 | 0.060 |
Why?
|
Flavivirus | 1 | 2024 | 22 | 0.060 |
Why?
|
Animals | 11 | 2022 | 167940 | 0.060 |
Why?
|
Erythrocytes | 2 | 2012 | 2415 | 0.060 |
Why?
|
Genetic Loci | 1 | 2013 | 2618 | 0.060 |
Why?
|
Temperature | 1 | 2010 | 2221 | 0.060 |
Why?
|
Protein Binding | 1 | 2016 | 9336 | 0.060 |
Why?
|
Recurrence | 1 | 2016 | 8487 | 0.060 |
Why?
|
Models, Genetic | 1 | 2013 | 3442 | 0.050 |
Why?
|
Inflammation | 2 | 2021 | 10757 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15827 | 0.050 |
Why?
|
Receptors, Chemokine | 1 | 2005 | 654 | 0.050 |
Why?
|
National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2022 | 62 | 0.050 |
Why?
|
Malaria | 1 | 2012 | 1226 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7809 | 0.050 |
Why?
|
Arthropod Vectors | 1 | 2020 | 6 | 0.050 |
Why?
|
Vero Cells | 1 | 2022 | 484 | 0.050 |
Why?
|
Complement C5 | 1 | 2021 | 106 | 0.050 |
Why?
|
Ticks | 1 | 2020 | 70 | 0.050 |
Why?
|
Stroke | 1 | 2023 | 9945 | 0.040 |
Why?
|
Life Cycle Stages | 1 | 2020 | 160 | 0.040 |
Why?
|
RNA, Messenger | 2 | 2012 | 12762 | 0.040 |
Why?
|
Cells, Cultured | 2 | 2020 | 18968 | 0.040 |
Why?
|
Vaccination | 2 | 2022 | 3360 | 0.040 |
Why?
|
Molecular Epidemiology | 1 | 2021 | 469 | 0.040 |
Why?
|
Introns | 2 | 2013 | 978 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15766 | 0.040 |
Why?
|
Contact Tracing | 1 | 2021 | 268 | 0.040 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2023 | 787 | 0.040 |
Why?
|
Bone Marrow Transplantation | 1 | 2007 | 2696 | 0.040 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2021 | 330 | 0.040 |
Why?
|
Quality Control | 1 | 2021 | 827 | 0.040 |
Why?
|
Mycophenolic Acid | 1 | 2021 | 343 | 0.040 |
Why?
|
Gene Expression | 1 | 2011 | 7592 | 0.040 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 361 | 0.040 |
Why?
|
Middle Aged | 9 | 2024 | 220175 | 0.040 |
Why?
|
Virulence | 1 | 2022 | 1295 | 0.040 |
Why?
|
Fluorescence | 1 | 2020 | 750 | 0.040 |
Why?
|
Limit of Detection | 1 | 2019 | 280 | 0.040 |
Why?
|
Dietary Fats | 1 | 2005 | 1992 | 0.040 |
Why?
|
Biological Assay | 1 | 2020 | 630 | 0.040 |
Why?
|
Tacrolimus | 1 | 2021 | 730 | 0.040 |
Why?
|
Chemokines | 1 | 2021 | 962 | 0.040 |
Why?
|
Adiposity | 1 | 2007 | 1851 | 0.040 |
Why?
|
Receptors, Virus | 1 | 2020 | 639 | 0.040 |
Why?
|
Workflow | 1 | 2021 | 851 | 0.030 |
Why?
|
Pandemics | 3 | 2022 | 8621 | 0.030 |
Why?
|
Male | 11 | 2024 | 359413 | 0.030 |
Why?
|
DNA, Bacterial | 1 | 2021 | 1455 | 0.030 |
Why?
|
Species Specificity | 1 | 2020 | 2413 | 0.030 |
Why?
|
Biological Evolution | 1 | 2022 | 1074 | 0.030 |
Why?
|
Kinetics | 1 | 2024 | 6378 | 0.030 |
Why?
|
Organ Specificity | 1 | 2020 | 1955 | 0.030 |
Why?
|
Syndrome | 2 | 2013 | 3278 | 0.030 |
Why?
|
Adult | 7 | 2024 | 219847 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 11902 | 0.030 |
Why?
|
Insulin Resistance | 2 | 2007 | 3960 | 0.030 |
Why?
|
Antibodies | 1 | 2023 | 2424 | 0.030 |
Why?
|
Blood-Brain Barrier | 1 | 2021 | 1017 | 0.030 |
Why?
|
Obesity | 2 | 2007 | 12915 | 0.030 |
Why?
|
Chemokine CCL2 | 2 | 2007 | 607 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2020 | 1791 | 0.030 |
Why?
|
Prospective Studies | 3 | 2024 | 54263 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 36247 | 0.030 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2018 | 664 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20048 | 0.030 |
Why?
|
RNA | 1 | 2023 | 2721 | 0.030 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3086 | 0.030 |
Why?
|
Genetic Markers | 1 | 2019 | 2608 | 0.030 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3206 | 0.030 |
Why?
|
Protein Conformation | 1 | 2020 | 3969 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2012 | 3774 | 0.030 |
Why?
|
Protein Processing, Post-Translational | 1 | 2020 | 1977 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2020 | 1447 | 0.020 |
Why?
|
Aged | 5 | 2024 | 168995 | 0.020 |
Why?
|
Female | 9 | 2024 | 391011 | 0.020 |
Why?
|
K562 Cells | 1 | 2013 | 640 | 0.020 |
Why?
|
AT Rich Sequence | 1 | 2010 | 10 | 0.020 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 12602 | 0.020 |
Why?
|
Inhibitory Concentration 50 | 1 | 2012 | 465 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2020 | 4264 | 0.020 |
Why?
|
Base Composition | 1 | 2010 | 290 | 0.020 |
Why?
|
Models, Molecular | 1 | 2020 | 5429 | 0.020 |
Why?
|
Pseudogenes | 1 | 2010 | 103 | 0.020 |
Why?
|
Disease Management | 1 | 2020 | 2508 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2013 | 1168 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2024 | 80301 | 0.020 |
Why?
|
Parasites | 1 | 2012 | 162 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2011 | 17766 | 0.020 |
Why?
|
Odds Ratio | 1 | 2021 | 9712 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8805 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2012 | 988 | 0.020 |
Why?
|
Public Health | 1 | 2022 | 2655 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2018 | 1589 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2024 | 14656 | 0.020 |
Why?
|
Genes, Dominant | 1 | 2011 | 863 | 0.020 |
Why?
|
Health Personnel | 1 | 2022 | 3310 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2011 | 1993 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2021 | 4168 | 0.020 |
Why?
|
Hepatomegaly | 1 | 2007 | 84 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2021 | 3737 | 0.020 |
Why?
|
Drug Design | 1 | 2012 | 1062 | 0.020 |
Why?
|
Cytokines | 1 | 2021 | 7345 | 0.020 |
Why?
|
Alternative Splicing | 1 | 2011 | 1091 | 0.020 |
Why?
|
Mice, Obese | 1 | 2007 | 420 | 0.020 |
Why?
|
Exons | 1 | 2011 | 2391 | 0.020 |
Why?
|
Time Factors | 2 | 2022 | 40133 | 0.020 |
Why?
|
Child, Preschool | 2 | 2021 | 42034 | 0.020 |
Why?
|
RNA Splicing | 1 | 2010 | 914 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15273 | 0.020 |
Why?
|
Receptors, CCR2 | 1 | 2005 | 215 | 0.010 |
Why?
|
Crosses, Genetic | 1 | 2005 | 751 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 22041 | 0.010 |
Why?
|
Incidence | 1 | 2022 | 21378 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2020 | 9196 | 0.010 |
Why?
|
Cell Count | 1 | 2007 | 1838 | 0.010 |
Why?
|
Base Sequence | 1 | 2013 | 12447 | 0.010 |
Why?
|
Linear Models | 1 | 2012 | 5876 | 0.010 |
Why?
|
Cohort Studies | 1 | 2024 | 41317 | 0.010 |
Why?
|
Young Adult | 2 | 2021 | 58673 | 0.010 |
Why?
|
Adiponectin | 1 | 2007 | 1115 | 0.010 |
Why?
|
Adipocytes | 1 | 2007 | 1179 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 17628 | 0.010 |
Why?
|
Child | 2 | 2021 | 79758 | 0.010 |
Why?
|
Adolescent | 2 | 2021 | 87747 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2007 | 22025 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2021 | 58947 | 0.010 |
Why?
|
Phenotype | 1 | 2012 | 16543 | 0.010 |
Why?
|
Brain | 1 | 2021 | 26912 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2005 | 3293 | 0.010 |
Why?
|
Blood Glucose | 1 | 2007 | 6375 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2005 | 14396 | 0.010 |
Why?
|
Mice | 2 | 2007 | 81216 | 0.010 |
Why?
|
Concepts
(253)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(109)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_